Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
13.86
-0.25 (-1.77%)
At close: May 30, 2025, 4:00 PM
13.69
-0.17 (-1.23%)
After-hours: May 30, 2025, 4:04 PM EDT

Sionna Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Net Income
-66.32-61.69-47.26-40.24
Depreciation & Amortization
0.660.670.580.12
Loss (Gain) From Sale of Investments
-3.59-3-0.68-0.4
Stock-Based Compensation
5.163.712.261.69
Other Operating Activities
10.610.62.18-
Change in Accounts Payable
2.350.470.16-1.51
Change in Other Net Operating Assets
-4.76-3.54-0.954.28
Operating Cash Flow
-55.9-52.79-43.7-36.07
Capital Expenditures
-0.11-0.03-1.12-1.87
Investment in Securities
-144.07-126.8928.47-27.39
Investing Cash Flow
-144.18-126.9127.35-29.26
Issuance of Common Stock
202.530.140.030.06
Other Financing Activities
-2.5-2.5--0.2
Financing Cash Flow
200.02178.970.03110.86
Net Cash Flow
-0.06-0.73-16.3245.52
Free Cash Flow
-56.01-52.81-44.82-37.94
Free Cash Flow Per Share
-5.75-13.69-15.28-14.72
Levered Free Cash Flow
--40.48-30.14-
Unlevered Free Cash Flow
--40.48-30.14-
Change in Net Working Capital
-0.730.41-
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q